Insights

PTAB Invalidates Two Anacor KERYDIN® Patents, PTAB Litigation Blog

Visit the Jones Day PTAB Litigation Blog.

The PTAB found obvious all claims of U.S. Patent Nos. 7,582,621 and 7,767,657 in the three final written decisions issued on February 23, 2017 (IPR2015-01776, IPR2015-01780, and IPR2015-01785).  This marks another victory for Coalition for Affordable Drugs (CFAD) — the petitioner in all three IPRs.

Read the full article at ptablitigationblog.com.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.